Saito A, Maeda K, Naotsuka T, Kobayashi K, Sugiyama S
Contrib Nephrol. 1977;6:141-52. doi: 10.1159/000399760.
Administering 15N-labelled glycine, 15 N incorporation into serum albumin and its excretion into urine and feces, together with nitrogen balance were investigated in 3 nephrotic and 2 normal adults. Furthermore, 15N-labelled urea was injected into a nephrotic adult and a glomerulonephritic adult, both advanced in azotemia and treated on low protein diet, and a normal subject on a normal diet, to examine the amounts of 15N incorporation into serum albumin. In the 3 nephrotic patients whose nitrogen balance was almost maintained, incorporation of 15N-glycine into serum albumin has been proved greater than in the normal subjects. In any of the above patients, 15N excretion into urine was less than in the normal subjects. Fecal 15N excretion was 2.0--2.5 % of the doses, indicating that approximately 98 % of 15N-glycine was absorbed. In the nephrotic patients, 15N incorporation into serum albumin examined by 15N-labelled urea administration was more accelerated than in the glomerulonephritic patients and was negligible in the control subject on a normal diet.
对3名肾病患者和2名正常成年人进行了研究,给他们施用15N标记的甘氨酸,检测15N掺入血清白蛋白以及其经尿液和粪便的排泄情况,同时检测氮平衡。此外,给1名氮质血症晚期且采用低蛋白饮食治疗的肾病成年患者、1名肾小球肾炎成年患者以及1名正常饮食的正常受试者注射15N标记的尿素,以检测15N掺入血清白蛋白的量。在3名氮平衡基本维持的肾病患者中,已证实15N-甘氨酸掺入血清白蛋白的量高于正常受试者。在上述任何患者中,经尿液排泄的15N均低于正常受试者。粪便中15N的排泄量为给药剂量的2.0% - 2.5%,表明约98%的15N-甘氨酸被吸收。在肾病患者中,通过施用15N标记的尿素检测发现,15N掺入血清白蛋白的速度比肾小球肾炎患者更快,而在正常饮食的对照受试者中可忽略不计。